Hollow structured upconversion luminescent NaYF4:Yb3+, Er3+ nanospheres for cell imaging and targeted anti-cancer drug delivery

Biomaterials

Volumn 34, Issue 5, 2013, Pages 1601-1612

  Yang, Dongmei ^a,b   Kang, Xiaojiao ^a,b   Ma, Ping'an ^a   Dai, Yunlu ^a,b   Hou, Zhiyao ^a   Cheng, Ziyong ^a   Li, Chunxia ^a   Lin, Jun ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Cell imaging; Drug delivery; Hollow structure; NaYF4; Upconversion

Indexed keywords

ANTI-CANCER DRUG DELIVERY; ANTICANCER DRUG; BACKGROUND NOISE; CANCER-TARGETING; CELL IMAGING; CELL UPTAKE; DRUG STORAGE; FOLIC ACIDS; FREE AMINES; GREEN EMISSIONS; HELA CELL; HOLLOW STRUCTURE; INTERIOR STRUCTURE; ION EXCHANGE PROCESS; LUMINESCENT PROPERTY; MESOPOROUS SHELL; MESOPOROUS STRUCTURES; NAYF4; POLYETHYLENIMINES; UP-CONVERSION;

DERIVATIVES; DRUG DELIVERY; ERBIUM; LASER EXCITATION; LUMINESCENCE; MOLECULAR BIOLOGY; ORGANIC ACIDS; YTTERBIUM;

NANOSPHERES;

DOXORUBICIN; ERBIUM; FOLIC ACID; NANOSPHERE; POLYETHYLENEIMINE; SODIUM DERIVATIVE; SODIUM TETRAFLUOROBORATE; UNCLASSIFIED DRUG; YTTERBIUM;

ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG RELEASE; DRUG SOLUBILITY; DRUG TARGETING; ENDOCYTOSIS; HELA CELL; HUMAN; HUMAN CELL; LUMINESCENCE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL SURVIVAL; CONTRAST MEDIA; DOXORUBICIN; FLUORIDES; HELA CELLS; HUMANS; LUMINESCENT MEASUREMENTS; NANOCAPSULES; NANOSPHERES; POROSITY; YTTRIUM;

EID: 84870671568     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.11.004     Document Type: Article

References (58)

1. Yang P.P., Gai S.L., Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev 2012, 41:3679-3698.
2. Cheng K., Sun S.H. Recent advances in syntheses and therapeutic applications of multifunctional porous hollow nanoparticles. Nano Today 2010, 5:183-196.
3. Fan H.J., Knez M., Scholz R., Nielsch K., Pippel E., Hesse D. Monocrystalline spinel nanotube fabrication based on the kirkendall effect. Nat Mater 2006, 5:627-631.
4. Yan E.Y., Fu Y.L., Wang X., Ding Y., Qian H.Q., Wang C.H. Hollow chitosan silica nanospheres for doxorubicin delivery to cancer cells with enhanced antitumor effect in vivo. J Mater Chem 2011, 21:3147-3155.
5. Huang C.C., Huang W., Yeh C.S. Shell-by-shell synthesis of multi-shelled mesoporous silica nanospheres for optical imaging and drug delivery. Biomaterials 2011, 32:556-564.
6. Kim M.H., Na H.K., Kim Y.K., Ryoo S.R., Cho H.S., Lee K.E., et al. Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery. ACS Nano 2011, 5:3568-3576.
7. 4@mesoporous silica nanospheres for biomedical applications. Adv Healthc Mater 2012, 1:327-331.
8. Tu H.L., Lin Y.S., Lin H.Y., Hung Y., Lo L.W., Chen Y.F., et al. In vitro studies of functionalized mesoporous silica nanoparticles for photodynamic therapy. Adv Mater 2009, 21:172-177.
9. Carlos L.D., Ferreira R.A.S., de Zea Bermudez V., Julián-López B., Escribano P. Progress on lanthanide-based organic-inorganic hybrid phosphors. Chem Soc Rev 2011, 40:536-549.
10. Kim J.Y., Kim H.S., Lee N., Kim T., Kim H., Yu T., et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed 2008, 47:8438-8441.
11. Chen Y., Chen H.R., Zhang S.J., Chen F., Zhang L.X., Zhang J.M., et al. Multifunctional mesoporous nanoellipsoids for biological bimodal imaging and magnetically targeted delivery of anticancer drugs. Adv Funct Mater 2011, 21:270-278.
12. Kim J., Piao Y.Z., Hyeon T. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem Soc Rev 2009, 38:372-390.
13. Kang X.J., Cheng Z.Y., Yang D.M., Ma P.A., Shang M.M., Peng C., et al. Design and synthesis of multifunctional drug carriers based on luminescent rattle-type mesoporous silica microspheres with a thermosensitive hydrogel as a controlled switch. Adv Funct Mater 2012, 22:1470-1481.
14. Luo B., Xu S., Luo A., Wang W.R., Wang S.L., Guo J., et al. Mesoporous biocompatible and acid-degradable magnetic colloidal nanocrystal clusters with sustainable stability and high hydrophobic drug loading capacity. ACS Nano 2011, 5:1428-1435.
15. Xing R.M., Liu S.H. Facile synthesis of the fluorescent porous zinc sulfide nanospheres and their application for potential drug delivery and live cell imaging. Nanoscale 2012, 4:3135-3140.
16. Gu J.L., Su S.S., Li Y.S., He Q.J., Shi J.L. Hydrophilic mesoporous carbon nanoparticles as carriers for sustained release of hydrophobic anti-cancer drugs. Chem Commum 2011, 47:2101-2103.
17. Xia Y.N., Li W.Y., Cobley C.M., Chen J.Y., Xia X.H., Zhang Q., et al. Gold nanocages: from synthesis to theranostic applications. Acc Chem Res 2011, 44:914-924.
18. 4 nanocrystals. Adv Funct Mater 2009, 19:853-859.
19. Wang Z.L., Hao J.H., Chan H.L.W., Law G.L., Wong W.T., Wong K.L., et al. Simultaneous synthesis and functionalization of water-soluble up-conversion nanoparticles for in-vitro cell and nude mouse imaging. Nanoscale 2011, 3:2175-2181.
20. 3 nanoparticles as robust down- and upconverting biolabels. Chem Eur J 2006, 12:5878-5884.
21. Vetrone F., Naccache R., Zamarron A., de la Futente A.J., Sanz-Rodriguez F., Martinez Maestro L., et al. Temperature sensing using fluorescent nanothermometers. ACS Nano 2010, 4:3254-3258.
22. Wang F., Han Y., Lim C.S., Lu Y.H., Wang J., Xu J., et al. Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature 2010, 463:1061-1065.
23. Carlos L.D., Ferreira R.A.S., De Zea Bermudez V., Ribeiro S.J.L. Lanthanide-containing light-emitting organic-inorganic hybrids: a bet on the future. Adv Mater 2009, 21:509-534.
24. 3+x nanocrystals: crystal structure evolution and multicolor tuning. J Am Chem Soc 2012, 134:8340-8343.
25. Wang F., Banerjee D., Liu Y.S., Chen X.Y., Liu X.G. Upconversion nanoparticles in biological labeling, imaging, and therapy. Analyst 2010, 135:1839-1854.
26. Wang C., Cheng L., Liu Z. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials 2011, 32:1110-1120.
27. 4 nanocrystals. Angew Chem Int Ed 2011, 50:6306-6310.
28. 3+ doped fluoride nanophosphors. Nano Lett 2008, 8:3834-3838.
29. 4 at low temperature. Chem Commun 2011, 47:5801-5803.
30. Li L.L., Zhang R.B., Yin L.L., Zheng K.Z., Qin W.P., Selvin P.R., et al. Biomimetic surface engineering of lanthanide-doped upconversion nanoparticles as versatile bioprobes. Angew Chem Int Ed 2012, 51:6121-6125.
31. Cao T.Y., Yang Y., Gao Y., Zhou J., Li Z.Q., Li F.Y. High-quality water-soluble and surface-functionalized upconversion nanocrystals as luminescent probes for bioimaging. Biomaterials 2011, 32:2959-2968.
32. 4 nanocrystals. Adv Mater 2010, 22:3266-3271.
33. Qian H.S., Guo H.C., Ho P.C.L., Mahendran R., Zhang Y. Mesoporous-silica-coated up-conversion fluorescent nanoparticles for photodynamic therapy. Small 2009, 5:2285-2290.
34. Zhang F., Braun G.B., Pallaoro A., Zhang Y.C., Shi Y.F., Cui D.X., et al. Mesoporous multifunctional upconversion luminescent and magnetic " nanorattle" materials for targeted chemotherapy. Nano Lett 2012, 12:61-67.
35. Liu Z., Sun L.N., Li F.Y., Shi L.Y., Zhang D.S., Yuan S., et al. One-pot self-assembly of multifunctional mesoporous nanoprobes with magnetic nanoparticles and hydrophobic upconversion nanocrystals. J Mater Chem 2011, 21:17615-17618.
36. Liu J.N., Bu W.B., Zhang S.J., Chen F., Xing H.Y., Pan L.M., et al. Controlled synthesis of uniform and monidisperse upconversion core/mesoporous silia shell nanocomposites for biomodal imaging. Chem Eur J 2012, 18:2335-2341.
37. Zhang F., Shi Y.F., Sun X.H., Zhao D.Y., Stucky G.D. Formation of hollow upconversion rare-earth fluoride nanospheres: nanoscale kirkendall effect during ion exchange. Chem Mater 2009, 21:5237-5243.
38. Lechevallier S., Lecante P., Mauricot R., Dexpert H., Dexpert-Ghys J., Kong H.K., et al. Gadolinium-europium carbonate particles: controlled precipitation for luminescent biolabeling. Chem Mater 2010, 22:6153-6161.
39. Rosenholm J.M., Meinander A., Peuhu E., Niemi R., Eriksson J.E., Sahlgren C., et al. Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano 2009, 3:197-206.
40. Setua S., Menon D., Asok A., Nair S., Koyakutty M. Folate receptor targeted, rare-earth oxide nanocrystals for bi-modal fluorescence and magnetic imaging of cancer cells. Biomaterials 2010, 31:714-729.
41. Wu H.X., Liu G., Zhang S.J., Shi J.L., Zhang L.X., Chen Y., et al. Biocompatibility, MR imaging and targeted drug delivery of a rattle-type magnetic mesoporous silica nanosphere system conjugated with PEG and cancer-cell-specific ligands. J Mater Chem 2011, 21:3037-3045.
42. 3+ hollow spheres as drug carriers. Biomaterials 2011, 32:4161-4173.
43. 3: synthesis and applications of magnetic resonance contrast agents and template particles for hollow spheres and hybrid composites. Adv Funct Mater 2008, 18:766-776.
44. 4 nanoparticles with upconversion fluorescence. Nanotechnology 2006, 17:5786-5791.
45. 2 hollow mesoporous spheres for targeted anticancer drug delivery. J Phys Chem C 2010, 114:16382-16388.
46. Sing K.S.W., Everett D.H., Haul R.A.W., Moscou L., Pierotti R.A., Rouquerol J., et al. Reporting physisorption data for gas solid systems with special reference to the determination of surface-area and porosity (recommendations 1984). Pure Appl Chem 1985, 57:603-619.
47. 3 particles. Chem Mater 2008, 20:3840-3848.
48. 2 hollow spheres. Langmuir 2008, 24:547-550.
49. Di W.H., Ren X.G., Zhao H.F., Shirahata N., Sakka Y., Qin W.P. Single-phased luminescent mesoporous nanoparticles for simultaneous cell imaging and anticancer drug delivery. Biomaterials 2011, 32:7226-7233.
50. 3+-poly(acrylic acid) hybrid microspheres. Biomaterials 2012, 33:2583-2592.
51. Zhang Q., Lee I., Ge J.P., Zaera F., Yin Y.D. Surface-orotected etching of mesoporous oxide shells for the stabilization of metal nanocatalysts. Adv Funct Mater 2010, 20:2201-2214.
52. Wang X., Zhuang J., Peng Q., Li Y.D. A general strategy for nanocrystal synthesis. Nature 2005, 437:121-124.
53. 2 nanocrystals: crystal-Field kevels, excited-State dynamics, upconversion and defect luminescenc. Small 2011, 7:3046-3056.
54. Drummond D.C., Zignani M., Leroux J.C. Current status of pH-sensitive liposomes in drug delivery. Prog Lipid Res 2000, 39:409-460.
55. Bhujwalla Z.M., Artemov D., Ballesterors P., Cerdan S., Gillies R.J., Solaiyappan M. Combined vascular and extracellular pH imaging of solid tumors. NMR Biomed 2002, 15:114-119.
56. Zhao Y., Lin L.N., Lu Y., Chen S.F., Dong L., Yu S.H. Templating synthesis of preloaded doxorubicin in hollow mesoporous dilica nanospheres for biomedical applications. Adv Mater 2010, 22:5255-5259.
57. 3 particles and the application as anticancer drug carrier. J Am Chem Soc 2008, 130:15808-15810.
58. Sudimack J., Lee R.J. Targeted drugdelivery via the folate receptor. Adv Drug Deliv Rev 2000, 41:147-162.